Christopher Hawkey, Professor of Gastroenterology

Introducing the section, Times Medical Correspondent Dr Mark Porter said: “Over the past six months a team of Times researchers asked charities, specialists and professional bodies and associations to come up with a list of leaders in their particular field. Some names appeared on everyone’s lists and it is these names that we have recommended … they are not just extraordinary doctors, but extraordinary people.”

“It’s an introduction to some of the medics who save and improve our lives every day.” – The Times Top Doctors Issue Editor, Lisa Grainger

Appearing in the 13th November’s magazine supplement, Professor Hawkey is one of just nine NIHR Senior Investigators to be featured in the guide and confirms Nottingham’s status as a leading centre of gastroenterology research in the country.

Professor Hawkey’s citation reads:

“Has pioneered the development of stem-cell transplantation for sufferers of Crohn’s disease. Campaigned for greater awareness of the dangers of obesity and alcohol while president of the British Society of Gastroenterology, saying alcohol is more pernicious than smoking.”

Chris Hawkey’s valuable work on Crohn’s and stem cells is ongoing within the Nottingham Digestive Diseases Centre BRU. He is Chief Investigator for the ASTIC trial (Autologous Stem Cell Transplantation for Crohn’s Disease). This is an international phase III study conducted by the European Crohn’s and Colitis Organisation (ECCO) and sponsored by the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Related Pages